Cargando…

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection

Taken from the largest U.S. cohort of patients with SARS-CoV2, our results demonstrate the association of even partial vaccination with lower risk of MACE after SARS-CoV-2 infection.

Detalles Bibliográficos
Autores principales:	Jiang, Joy, Chan, Lili, Kauffman, Justin, Narula, Jagat, Charney, Alexander W., Oh, Wonsuk, Nadkarni, Girish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American College of Cardiology Foundation. Published by Elsevier. 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939951/ https://www.ncbi.nlm.nih.gov/pubmed/36813689 http://dx.doi.org/10.1016/j.jacc.2022.12.006

Ejemplares similares

IMPACT OF VACCINATION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH COVID-19
por: Jiang, Joy, et al.
Publicado: (2023)

A foundational vision transformer improves diagnostic performance for electrocardiograms
por: Vaid, Akhil, et al.
Publicado: (2023)

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
por: Dougados, Maxime, et al.
Publicado: (2023)

Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter]
por: Shuja, Muhammad Hamza, et al.
Publicado: (2023)

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
por: Paranjpe, Ishan, et al.
Publicado: (2020)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Incidence of Major Adverse Cardiovascular Events and Cardiac Mortality in High-Risk Kidney-Only and Simultaneous Pancreas−Kidney Transplant Recipients
por: Lim, Wai H., et al.
Publicado: (2021)

Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker
por: Lee, S R, et al.
Publicado: (2023)

Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients
por: Lee, Mi Jung, et al.
Publicado: (2014)

Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events
por: Versteylen, Mathijs O., et al.
Publicado: (2011)

Association between Aortic Valve Sclerosis and Adverse Cardiovascular Events
por: Lucena, Cristiane Machado, et al.
Publicado: (2015)

Prevalence and trends of perioperative major adverse cardiovascular and cerebrovascular events during cancer surgeries
por: Ramamoorthy, Venkataraghavan, et al.
Publicado: (2023)

Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Dutch Perspectives Toward Governmental Trust, Vaccination, Myths, and Knowledge About Vaccines and COVID-19
por: Yousuf, Hamza, et al.
Publicado: (2021)

Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
por: Shin, Hye-Rim, et al.
Publicado: (2022)

Neurological Adverse Events Associated with COVID-19 Vaccination
por: Jadali, Zohreh
Publicado: (2023)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

Quantitative prediction of right ventricular and size and function from the electrocardiogram
por: Duong, Son Q., et al.
Publicado: (2023)

COVID-19 and the Prehospital Incidence of Acute Cardiovascular Events (from the Nationwide US EMS)
por: Shekhar, Aditya C., et al.
Publicado: (2020)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

The Authors Reply:
por: Sud, Karan, et al.
Publicado: (2020)

Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease
por: Ye, Xuxiao, et al.
Publicado: (2022)

COVID-19 vaccine-related psychiatric adverse events: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population
por: Mendonça, Maria Isabel, et al.
Publicado: (2021)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Necroptosis Drives Major Adverse Cardiovascular Events During Severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Ten-year predictors of major adverse cardiovascular events in patients without angina
por: Premsagar, Preesha, et al.
Publicado: (2023)

Covid-19 vaccination, adverse events, and detection of antibodies
por: Kristensen, Søren Risom, et al.
Publicado: (2021)

Addressing the Global Burden of Cardiovascular Diseases; Need for Scalable and Sustainable Frameworks
por: Mendis, Shanthi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nvve2uqasdmsc9sv7oq6o19sea